AURKA and breast cancer: Upon investigating the prognostic impact of AURKA expression in individual molecular breast cancer subtypes, we found that high AURKA expression was associated with reduced disease-specific and recurrence-free survival in luminal A tumors (Fig. 3G–H; METABRIC discovery (all ages, n = 1784) and KM-plotter data, respectively).